Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00327860 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
NotableTrial status: Active, Not Recruiting to Recruitingv25Show 7 more changesShow less
Enrollment target: 1100 to 1300
Eligibility criteria expanded, about 44 words
Secondary endpoints: 1 to 2
Study description expanded, about 74 words
Site details revised at 2 of 2 sites
Publications: 195 to 203
Study arms: 3 to 4
MinorPublications: 183 to 195v24
NotablePrimary and study completion dates: Jul 2023 to Jul 2028
Primary endpoint revised
Secondary endpoint revised
v23
MinorPublications: 165 to 183v22
Show 20 earlier versionsHide 20 earlier versions
MinorPublications: 138 to 165v21
MinorTrial status: Recruiting to Active, Not Recruiting
Enrollment target: estimated 1081 to confirmed 1100
Site details revised at 2 of 2 sites
Publications: 116 to 138
v20
MinorRe-verified, no change to tracked fieldsv19
MinorPublications: 98 to 116v18
NotablePrimary and study completion dates: Jul 2018 to Jul 2023v17Show 4 more changesShow less
Enrollment target: 1196 to 1081
Secondary endpoints: details revised at 1 of 1 entry
Site contacts updated at 2 of 2 sites
Publications: 88 to 98
NotableTrial status: Active, Not Recruiting to Recruitingv16Show 4 more changesShow less
Enrollment target: 891 to 1196
Eligibility criteria expanded, about 75 words
Study sites revised (2)
Publications: 71 to 88
MinorSecondary endpoint revised
Eligibility criteria expanded, about 2 words
v15
MinorStudy description expanded, about 50 words
Publications: 61 to 71
v14
MinorTrial status: Recruiting to Active, Not Recruitingv13Show 5 more changesShow less
Enrollment target: estimated 830 to confirmed 891
Eligibility criteria revised
Site details revised at 2 of 2 sites
Collaborators: 4 to 3
Publications: 48 to 61
MinorPrimary completion date: Jul 2018
Study completion date: Jul 2013 to Jul 2018
Publications: 26 to 48
v12
MinorRe-verified, no change to tracked fieldsv11
NotableLead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Johns Hopkins Bloomberg School of Public Healthv10Show 6 more changesShow less
Trial status: Active, Not Recruiting to Recruiting
Enrollment target: 540 to 830
Study completion date: Jul 2008 to Jul 2013
Study sites revised (2)
Collaborators: 3 to 4
Publications: 10 to 26
MinorEligibility criteria revisedv9
MinorTrial status: Recruiting to Active, Not Recruiting
Site details revised at 2 of 2 sites
v8
MinorRe-verified, no change to tracked fieldsv7
MinorStudy completion date: Jul 2008
Site contacts updated at 1 of 2 sites
v6
Minor4 versionsRe-verified since Oct 16, 2006, no change to tracked fieldsv2-v5
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The Division of Kidney, Urologic, and Hematologic Diseases (DKUHD) of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Heart, Lung and Blood Institute (NHLBI) funded a cooperative agreement including two Clinical Coordinating Centers (at Children's Hospital of Philadelphia and at Children's Mercy Hospital in Kansas City), a central biochemistry laboratory (at the University of Minnesota) and a Data Coordinating Center (at Johns Hopkins School of Public Health) to conduct a prospective epidemiological study of children with chronic kidney disease (CKD).
Trial Details
NCT Number
NCT00327860
Lead Sponsor
Johns Hopkins Bloomberg School of Public Health Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Heart, Lung, and Blood Institute (NHLBI)